2025-02-02 15-20-05
Content
- Cognitive Performance during Hypoglycemia is not reduced in people with Type 1 Diabetes when they take Medium Chain Triglycerides (MCTs) during hypoglycemia due to an increase in plasma Beta-Hydroxybutyrate (BHB)
References
| Quick Notes3 | |
|---|---|
| 2025-02-02 15-18-53 | Synaptic activity of rat hippocampal brain slices is not improved by Octanoate (C8 MCT) during Hypoglycemia in vitro |
| 2025-02-02 15-15-56 | Synaptic activity of rat hippocampal brain slices is improved by Beta-Hydroxybutyrate (BHB) during Hypoglycemia in vitro |
| 2025-02-02 14-55-33 | Cognitive Performance is not reduced during Insulin-induced Hypocalcemia in people with Type 1 Diabetes when they take Medium Chain Triglycerides (MCTs) during hypoglycemia |
| Original Sources1 | Citations |
|---|---|
| pageMediumChainFattyAcids2009 | Page, Kathleen A., Anne Williamson, Namyi Yu, Ewan C. McNay, James Dzuira, Rory J. McCrimmon, and Robert S. Sherwin. “Medium-Chain Fatty Acids Improve Cognitive Function in Intensively Treated Type 1 Diabetic Patients and Support In Vitro Synaptic Transmission During Acute Hypoglycemia.” Diabetes 58, no. 5 (May 2009): 1237–44. https://doi.org/10.2337/db08-1557. |